Indo US Bio-Tech Ltd (INDOUS) is currently trading at 77.06 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Indo Us Bio-Tech Limited is a leading seed company in India, focused on crop research, breeding, and seed production. Originally established as Pollucid Bio-Tech in 2004, the company underwent several name changes before becoming a public limited company in 2018. The company operates seed processing plants in Gujarat, utilizing modern technologies to process, store, and pack seeds. Indo Us Bio-Tech boasts a robust network of over 2500 distributors and dealers across India, emphasizing its growth and market presence. The company is involved in extensive R&D, developing a diverse range of germplasm varieties and marketing products under multiple brand names.

Over the past 52 weeks, Indo US Bio-Tech Ltd has traded between a low of ₹72.60 and a high of ₹158.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Indo US Bio-Tech Ltd has a market capitalization of approximately 154.52. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Indo US Bio-Tech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 13.48 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 154.52 Cr, Indo US Bio-Tech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Indo US Bio-Tech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Indo US Bio-Tech Ltd is 13.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.